Medical journal publishes controversial study of Vioxx


  • Health
  • Tuesday, 25 Jan 2005

LONDON (AP) - A medical journal published a study Tuesday of deaths related to the anti-inflammatory drug Vioxx after withholding the report because the researcher said he had been threatened by superiors at the U.S. Food and Drug Administration. 

The Lancet, which originally planned to publish the paper on Nov. 17, released the study online. 

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Health

Atrial fibrillation: Higher risk for heart failure than stroke
Five things that make us happy
Working atypical hours is bad for your health
Diagnosing prostate cancer too early might cause more harm than good
Consensual 'touch interventions' boost both physical and mental health
Beware the sting of wasps and hornets as it could be fatal
Practise 'speech fasting' for heart, brain and mental benefits
Delivering drugs through the skin
Ladies, eat a Japanese diet to protect your brain
Our sense of balance is crucial to prevent falls

Others Also Read